Spilcare O-Metaclen Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-07-2024
- Paid Up Capital ₹ 0.20 M
as on 04-07-2024
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.50 M
as on 04-07-2024
- Revenue -57.58%
(FY 2020)
- Profit -99.71%
(FY 2020)
- Ebitda 114.67%
(FY 2020)
- Net Worth 0.02%
(FY 2020)
- Total Assets -11.10%
(FY 2020)
About Spilcare O-Metaclen
The Corporate was formerly known as Spilcare-O-Metaclen Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹2.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Tripta Khanna and Nitin Khanna serve as directors at the Company.
- CIN/LLPIN
U52599TN1994PTC028944
- Company No.
028944
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Spilcare O-Metaclen Private Limited offer?
Spilcare O-Metaclen Private Limited offers a wide range of products and services, including Pollution Control Devices & Machines, Spill Control Equipment, Cleaning Liquids & Wipes, Cleaning Chemicals, Fire Fighting & Prevention Products, Fire Sprinklers, Industrial Chemicals & Supplies, Oil Field Chemical, Automotive Cleaners.
Who are the key members and board of directors at Spilcare O-Metaclen?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nitin Khanna | Managing Director | 18-Oct-1994 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Tripta Khanna | Director | 18-Oct-1994 | Current |
Financial Performance of Spilcare O-Metaclen.
Spilcare O-Metaclen Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 57.58% decrease. The company also saw a substantial fall in profitability, with a 99.71% decrease in profit. The company's net worth moved up by a moderate rise of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Spilcare O-Metaclen?
In 2020, Spilcare O-Metaclen had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 14 Oct 1995 | ₹2.50 M | Satisfied |
How Many Employees Work at Spilcare O-Metaclen?
Unlock and access historical data on people associated with Spilcare O-Metaclen, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spilcare O-Metaclen, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spilcare O-Metaclen's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.